To foster support for this novel technology and procedure, TVA Medical turned to LLSS to develop their medical affairs and global commercialization plans. Given our extensive experience in strategic development and commercial operations, our team of executive-level consultants were ableto immediately plug in to the DNA of TVA Medical to understand its unique challenges.
We created a strategic framework that articulated launch readiness and budget allocation, especially for the board which required clearer context for funding requests. To reassure the board money was being spent wisely we tapped our 125 years of collective leadership experience at life science companies to establish a disciplined spending approach that prioritized when and where investor dollars should be used.
Impressed with our ability to rapidly integrate within their internal teams, TVA Medical asked us to create a playbook for its strategic imperatives. Our team outlined a path to accelerate both clinical community support and clinical trial enrollment by positioning and messaging the core value proposition of the procedure and engaging all
the key stakeholders in the dialysis healthcare ecosystem. Our sales training and support materials helped their internal teams articulate these positions more effectively.